The FDA accepted a new drug application for K-911, an investigational eye drop for open-angle glaucoma or ocular hypertension ...

Doctors in Sydney, Australia, discovered Ayla Cullen had a grapefruit-sized kidney tumour after her mum spotted her mood ...

Mayo Clinic researchers have developed and externally validated an artificial intelligence (AI) model that can identify a potentially significant heart obstruction from routine ultrasound videos ...

Add Yahoo as a preferred source to see more of our stories on Google. Two New York ophthalmology practices have agreed to pay a combined $2.3 million to resolve allegations that they submitted ...

TAMPA, Fla. — Two New York ophthalmology practices have agreed to pay a combined $2.3 million to resolve allegations that they submitted fraudulent claims to Medicare and Medicaid for medically ...

Background/Aims To report visual and anatomical outcomes following intravitreal hydroxypropylmethylcellulose (HPMC) for the treatment of chronic structural hypotony. Methods This study is a ...

Rodriguez is in concussion protocol and will be reevaluated Friday, Daniel Kramer of MLB.com reports. Rodriguez was plunked in the back of the helmet by a throw from Nolan Schanuel in the bottom of ...

The Fourth of July is about to get a little safer. Nebraska Medicine ophthalmologist Dr. Rao Chundury and his children are promoting fireworks safety through their nonprofit, Eye On July, while ...

One of the most common vision changes we face as we age is bothersome flashes and eye floaters. In some cases, the little streaks of light and black spots don't mean anything, but other times they can ...

White was placed in the concussion protocol following Sunday's victory over the Dodgers, Mark Bowman of MLB.com reports. He made a spectacular catch to rob Max Muncy of an extra-base hit with two outs ...

The intention-to-treat population comprised 544 patients: 273 in the intervention group and 271 in the control group. The mean (±SD) age was 58.2±13.5 years, and 42.6% of the patients were women. A ...

A pair of rivals developing drugs for common retinal diseases are not seeing eye to eye. EyePoint on Friday filed a lawsuit in Massachusetts Superior Court accusing Ocular Therapeutix of engaging in a ...